Spinal Tumor Clinical Trials

7 recruiting

Spinal Tumor Trials at a Glance

13 actively recruiting trials for spinal tumor are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in London, Columbus, and Baltimore. Lead sponsors running spinal tumor studies include Cancer Research Antwerp, Clariance, and Aesculap AG.

Browse spinal tumor trials by phase

Treatments under study

About Spinal Tumor Clinical Trials

Looking for clinical trials for Spinal Tumor? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Spinal Tumor trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Spinal Tumor clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting

Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical

Degenerative Disc DiseaseSpinal TumorSpine Fracture+2 more
Aesculap AG200 enrolled4 locationsNCT05296889
Recruiting

Clariance ErYs Registry

Spinal TumorSpinal DeformitySpine Degeneration+2 more
Clariance760 enrolled1 locationNCT05170815
Recruiting
Not Applicable

SBRT Technique Implementation for Spinal Metastases Irradiation

Bone MetastasesSpinal MetastasesSpinal Tumors
Institute of Oncology Ljubljana100 enrolled2 locationsNCT07429422
Recruiting
Not Applicable

The Ailliance Post-Market Clinical Study

Spinal DeformitySpinal Degenerative DisorderSpinal Fusion Failure+2 more
Medtronic Spinal and Biologics1,000 enrolled24 locationsNCT05856370
Recruiting
Not Applicable

Liquid Biopsy Following BBB Disruption Using Barrier Disrupting Fields in Patients Undergoing Spine Surgery

Spinal Tumors
Sheba Medical Center20 enrolled1 locationNCT07224451
Recruiting

Multicenter Trial on Surgical Outcome and Quality of Life in Juxta-medullary Tumors

Intraspinal TumorJuxtamedullary Tumor
University Hospital Muenster100 enrolled1 locationNCT07056023
Recruiting

Swiss Spinal Tumor Registry (Swiss-STR)

Spinal TumorsSurgical Treatment
Luzerner Kantonsspital250 enrolled1 locationNCT06869746
Recruiting
Phase 2

Study of Olutasidenib and Temozolomide in HGG

Metastatic Brain TumorIDH1 MutationAstrocytoma, Grade IV+16 more
Rigel Pharmaceuticals60 enrolled18 locationsNCT06161974
Recruiting
Phase 1Phase 2

Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients

Metastasis Spinal Tumor
Second Affiliated Hospital, School of Medicine, Zhejiang University150 enrolled1 locationNCT06023212
Recruiting
Not Applicable

Evaluating the Efficacy and Safety of Intra-wound Vancomycin Powder in High Risk Patients

Surgical Site InfectionTraumaSpinal Tumor+1 more
The University of Hong Kong76 enrolled1 locationNCT03839914
Recruiting
Not Applicable

Separation Surgery Followed by Stereotactic Ablative Body Radiotherapy (SABR) Versus SABR Alone for Spinal Metastases

Solid TumorSpinal TumorSpinal Neoplasms
Cancer Research Antwerp128 enrolled9 locationsNCT06613295
Recruiting

Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors

Spinal Tumor
Peking University Third Hospital500 enrolled1 locationNCT06587022
Recruiting

En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor.

SurgeryRadiotherapySpinal Metastases+2 more
Shanghai Changzheng Hospital182 enrolled1 locationNCT06120426